OpenAlex
PricingAboutJobs
Log inGet started
Work

Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo

HTML

Year: 2017
Type: article
Source: Leukemia
DOI: 10.1038/leu.2017.87
Authors: H Zhou, P Y Mak, H Mu, D H Mak, Z Zeng, J Cortes, Q Liu, M Andreeff, B Z Carter
Institutions: The University of Texas MD Anderson Cancer Center, Nanfang Hospital, Southern Medical University
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic myeloid leukemia, blast crisis, β-catenin, BCR-ABL, tyrosine kinase inhibitor resistance, nilotinib, PRI-724, C82, Wnt/β-catenin signaling, mesenchymal stem cells, CD44, CFU-GM, c-Myc, survivin, STAT5, CRKL, engraftment, combination therapy
SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute
Awards: The Therapy of CML, Cancer Center Support Grant
OpenAlex ID: W2597879408
FWCI: 8.812
Cites: 59
Cited by: 98
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security